Wellness Mix ZPHC — 25 mg (Ipamorelin 2.5 mg + CJC-1295 2.5 mg) — 5 vials × 5 mg

Wellness Mix ZPHC: Product Overview

Wellness Mix ZPHC is a peptide combination product identified as containing Ipamorelin and CJC-1295, two compounds frequently discussed in research involving growth-hormone signaling. The listed presentation is 5 vials × 5 mg, with the product name describing a total labeled amount of 25 mg.

For people researching peptide products, understanding the exact formulation, labeling, concentration, storage requirements, and regulatory status is important before considering any product. Product descriptions should not be interpreted as medical advice, treatment recommendations, or instructions for self-administration.

Wellness Mix ZPHC Composition

The listed Wellness Mix formulation contains:

• Ipamorelin — 2.5 mg
• CJC-1295 — 2.5 mg
• Total per vial — 5 mg
• Package — 5 vials
• Total labeled quantity — 25 mg

The combination of Ipamorelin and CJC-1295 is commonly encountered in peptide research discussions because both compounds are associated with pathways involving growth-hormone release. However, the presence of these compounds in a product does not establish that the product is approved for a particular medical purpose.

Buyers and researchers should carefully compare the product label with the actual vial contents, packaging, batch information, and applicable regulatory requirements.

What Is Ipamorelin?

Ipamorelin is a synthetic peptide that has been studied for its interaction with growth-hormone secretagogue pathways. It is generally described as a selective growth-hormone secretagogue receptor agonist.

Interest in Ipamorelin has resulted in substantial discussion within peptide research communities. Nevertheless, online descriptions can vary considerably, and claims about benefits should not automatically be treated as established clinical evidence.

When evaluating a product containing Ipamorelin, relevant considerations include identity, purity, formulation, manufacturing controls, analytical testing, labeling accuracy, and intended research use.

What Is CJC-1295?

CJC-1295 is a synthetic peptide related to growth-hormone-releasing hormone (GHRH) research. It has been investigated for its effects on growth-hormone-related signaling and pharmacokinetic characteristics.

CJC-1295 may appear in different formulations or descriptions, so researchers should verify the exact form identified by the manufacturer. In particular, terminology surrounding CJC-1295 and DAC status can create confusion when comparing products.

A product listing should therefore provide sufficiently specific information to distinguish the formulation being offered.

Ipamorelin and CJC-1295 Combination

The Wellness Mix ZPHC formulation combines two peptides associated with research into growth-hormone signaling. This combination is one reason peptide enthusiasts and researchers may encounter similar formulations across the online peptide marketplace.

However, combining compounds does not automatically establish additional clinical effectiveness or safety. The appropriate interpretation depends on scientific evidence, product quality, intended use, and regulatory status.

A powerful product description should therefore prioritize transparent specifications rather than unsupported claims about body composition, recovery, anti-aging, athletic performance, or medical outcomes.

Product Specifications

The listed specifications for Wellness Mix ZPHC are:

Product: Wellness Mix ZPHC
Peptides: Ipamorelin + CJC-1295
Ipamorelin amount: 2.5 mg per listed formulation
CJC-1295 amount: 2.5 mg per listed formulation
Total amount: 5 mg per vial
Package size: 5 vials × 5 mg
Total labeled quantity: 25 mg

Always verify the current manufacturer label and accompanying documentation because product specifications can change between batches, markets, or suppliers.

Quality and Verification

Quality is an important consideration when researching peptide products. A product listing alone cannot establish purity, sterility, identity, potency, or manufacturing quality.

Where applicable, researchers should look for documentation such as:

• Batch or lot numbers
• Certificate of analysis documentation
• Identity testing
• Purity testing
• Manufacturing information
• Storage specifications
• Expiration or retest information
• Appropriate labeling
• Information regarding intended use

Independent analytical documentation can provide more meaningful information than marketing language alone. Particular care is warranted for products represented as sterile or injectable because contamination, incorrect concentration, or inadequate manufacturing controls can present significant risks.

Storage and Handling

Storage requirements depend on the manufacturer’s formulation and labeling. The manufacturer’s current instructions should take precedence over generalized online recommendations.

Researchers should avoid relying on assumptions about temperature, light exposure, reconstitution, or shelf life. Once a peptide product has been reconstituted or otherwise altered, its stability may differ from that of the original packaged material.

For this reason, the product’s official documentation should be consulted for specific storage and handling requirements.

Regulatory and Safety Considerations

Ipamorelin and CJC-1295 should not be treated as ordinary nutritional supplements simply because they are marketed through websites using terms such as “wellness,” “research,” or “peptide.”

Regulatory status and permitted uses can differ by jurisdiction. In the United States, individuals should verify applicable FDA information and consult a qualified healthcare professional before using an investigational or prescription-related compound.

Claims concerning weight management, muscle development, recovery, anti-aging, hormone optimization, or other health outcomes should be evaluated carefully. Research interest does not necessarily mean that a compound has been demonstrated to be safe and effective for those purposes.

Understanding the 5-Vial Presentation

The Wellness Mix ZPHC listing specifies five individual 5 mg vials. This can make the product easier to identify when comparing listings, but package quantity should not be confused with a clinically established dosage.

The stated 25 mg total is simply the sum of the five labeled 5 mg vials. It does not indicate how, when, or whether the contents should be administered.

Any administration decisions involving peptide compounds should be made only under appropriate professional medical guidance where legally and medically applicable.

Why Accurate Product Information Matters

Accurate product information is particularly important in the peptide marketplace. Similar names can refer to different concentrations, formulations, or versions of a compound.

For Wellness Mix ZPHC, the key identifiers are the combination of Ipamorelin and CJC-1295, the stated 2.5 mg + 2.5 mg composition, and the 5-vial × 5 mg presentation.

Researchers comparing peptide products should evaluate the complete label rather than relying solely on product names or promotional terminology.

Wellness Mix ZPHC Search Terms

Relevant informational search terms include ZPHC Wellness Mix, Wellness Mix ZPHC, Ipamorelin 2.5 mg, CJC-1295 2.5 mg, Ipamorelin and CJC-1295, ZPHC peptide formulation, 5 mg peptide vial, and 5 vials × 5 mg peptide.

These terms help distinguish the specific formulation from other peptide products containing either Ipamorelin or CJC-1295 separately.

Final Product Summary

Wellness Mix ZPHC is listed as a five-vial peptide formulation containing Ipamorelin and CJC-1295. Each vial is identified as containing 5 mg total, consisting of 2.5 mg Ipamorelin and 2.5 mg CJC-1295, for a stated package total of 25 mg.

Because peptide products can involve significant quality, regulatory, and safety considerations, prospective users should verify current labeling, analytical documentation, regulatory status, and professional guidance rather than relying on promotional claims. This information is provided for general educational and product-identification purposes and does not constitute medical advice or instructions for use.